Sigyn Therapeutics, Inc. Financial Ratios
SIGY|FY2019 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2019 SEC 10-K data.
DuPont ROE Decomposition (FY2019)
Return on Equity
-
Profit Margin
-2145.3%
Net Income / Revenue
Asset Turnover
-
Revenue / Total Assets
Equity Multiplier
0.00
Total Assets / Equity
Profitability
Liquidity
Current Ratio
646.82
Quick Ratio
0.55
Solvency
Interest Coverage
-2.60
Efficiency
Asset Turnover
-
Inventory Turnover
0.06
Days Sales Outstanding
-
As of FY2019 · SEC 10-K · Updated Jun 29, 2026